ATE319677T1 - Cholinderivate zur behandlung der alzheimerkrankheit - Google Patents

Cholinderivate zur behandlung der alzheimerkrankheit

Info

Publication number
ATE319677T1
ATE319677T1 AT01925883T AT01925883T ATE319677T1 AT E319677 T1 ATE319677 T1 AT E319677T1 AT 01925883 T AT01925883 T AT 01925883T AT 01925883 T AT01925883 T AT 01925883T AT E319677 T1 ATE319677 T1 AT E319677T1
Authority
AT
Austria
Prior art keywords
treatment
alzheimer
disease
choline derivatives
choline
Prior art date
Application number
AT01925883T
Other languages
English (en)
Inventor
Vincenzo Carelli
Felice Liberatore
Luigi Scipione
Mario Cardellini
D Rotiroti
V Rispoli
Original Assignee
Uni Degli Studi Di Roma Sla Sa
Uni Degli Studi Di Catanzaro S
Uni Degli Studi Camerino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi Di Roma Sla Sa, Uni Degli Studi Di Catanzaro S, Uni Degli Studi Camerino filed Critical Uni Degli Studi Di Roma Sla Sa
Application granted granted Critical
Publication of ATE319677T1 publication Critical patent/ATE319677T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01925883T 2000-04-21 2001-04-18 Cholinderivate zur behandlung der alzheimerkrankheit ATE319677T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000898A IT1318484B1 (it) 2000-04-21 2000-04-21 Derivati di colina per il trattamento della malattia di alzheimer.

Publications (1)

Publication Number Publication Date
ATE319677T1 true ATE319677T1 (de) 2006-03-15

Family

ID=11444910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925883T ATE319677T1 (de) 2000-04-21 2001-04-18 Cholinderivate zur behandlung der alzheimerkrankheit

Country Status (8)

Country Link
US (1) US20030166721A1 (de)
EP (1) EP1274674B1 (de)
AT (1) ATE319677T1 (de)
AU (1) AU5255501A (de)
DE (1) DE60117770T2 (de)
ES (1) ES2260215T3 (de)
IT (1) IT1318484B1 (de)
WO (1) WO2001081296A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1660434A1 (de) * 2003-08-15 2006-05-31 PATEL, Hasmukh B. Zur behandlung von kognitiven dysfunktionen und zur verbesserung der gedächtnisleistung, des lernens und des verstehens geeignete cholinester
US7803842B2 (en) 2004-06-08 2010-09-28 Hass Patel Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
US20060194723A1 (en) * 2005-02-28 2006-08-31 Rabinoff Michael D Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US5286637A (en) * 1989-08-07 1994-02-15 Debiopharm, S.A. Biologically active drug polymer derivatives and method for preparing same
GB2264707A (en) * 1991-06-18 1993-09-08 Roger Michael Marchbanks Acridine derivatives for treating alzheimer's disease
US5576283A (en) * 1992-08-14 1996-11-19 The Procter & Gamble Company Liquid detergents containing a peptide aldehyde
AU7113594A (en) * 1993-06-21 1995-01-17 Enzon, Inc. Site specific synthesis of conjugated peptides
SE9503380D0 (sv) * 1995-09-29 1995-09-29 Pharmacia Ab Protein derivatives
US5990237A (en) * 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines

Also Published As

Publication number Publication date
EP1274674B1 (de) 2006-03-08
ITMI20000898A0 (it) 2000-04-21
DE60117770T2 (de) 2006-12-14
US20030166721A1 (en) 2003-09-04
EP1274674A1 (de) 2003-01-15
IT1318484B1 (it) 2003-08-25
ES2260215T3 (es) 2006-11-01
ITMI20000898A1 (it) 2001-10-21
AU5255501A (en) 2001-11-07
WO2001081296A1 (en) 2001-11-01
DE60117770D1 (de) 2006-05-04

Similar Documents

Publication Publication Date Title
ATE344253T1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE273954T1 (de) Verbindungen zur anwendung bei der behandlung entzündlicher erkrankungen
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
ATE385794T1 (de) Benzothiazolderivate zur behandlung von alzheimer und parkinson
ATE343562T1 (de) Verbindungen und verfahren zur behandlung der alzheimerschen krankheit
UY26813A1 (es) Compuestos para tratar enfermedad de alzheimer
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60027290D1 (de) Skleraprothese zur behandlung der weitsichtigkeit und anderer augenkrankheiten
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE383853T1 (de) Arylessigsäuren und verwandte verbindungen zur behandlung von alzheimer-krankheit
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
ATE464048T1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
TR200200278T2 (tr) Kalsilitik bileşimler
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE319677T1 (de) Cholinderivate zur behandlung der alzheimerkrankheit
DE60130691D1 (de) Indolderivate zur Behandlung von Erkrankungen des Zentralnervensystems
DE60114668D1 (de) Prozess zur Herstellung des Anti-Migräne Wirkstoffs Eletriptan

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties